Published in Infect Immun on July 01, 1976
Suppression of immunological responses in mice by treatment with amphotericin B. Clin Exp Immunol (1979) 1.30
Effects of antifungal agents on the function of human neutrophils in vitro. Antimicrob Agents Chemother (1990) 1.08
Enhancement of macrophage superoxide anion production by amphotericin B. Antimicrob Agents Chemother (1991) 1.05
Neutrophil toxicity of amphotericin B. Antimicrob Agents Chemother (1977) 1.04
Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro. Antimicrob Agents Chemother (1992) 0.97
Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions. Antimicrob Agents Chemother (1988) 0.96
Stimulation of human and canine neutrophil metabolism by amphotericin B. Antimicrob Agents Chemother (1981) 0.96
Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Can Med Assoc J (1984) 0.85
Influence of antibiotics on formylmethionyl-leucyl-phenylalanine-induced leukocyte chemiluminescence. Antimicrob Agents Chemother (1987) 0.83
Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone). Antimicrob Agents Chemother (1992) 0.83
Simple procedure for measuring neutrophil chemiluminescence. J Clin Microbiol (1981) 0.82
Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells. Antimicrob Agents Chemother (1986) 0.79
Effects of quinolones on granulocyte function in vitro. Infection (1986) 0.77
Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1994) 0.76
Interference of granulocyte function by the vehicle of miconazole. Antimicrob Agents Chemother (1978) 0.75
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun (1972) 7.50
Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis (1974) 2.06
Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. Metabolism (1975) 1.78
The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia (1974) 1.69
Effects of tetracycline on leukotaxis. J Infect Dis (1974) 1.69
Inhibition by sulfonamides of the candidacidal activity of human neutrophils. J Clin Invest (1971) 1.30
Effects of 5-fluorocytosine on protein synthesis and amino acid pool in Candida albicans. Sabouraudia (1974) 1.01
In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest (1967) 10.26
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1969) 4.12
Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. Lancet (1966) 3.97
Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. J Immunol Methods (1977) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Genetic studies of a secondary RNA polymerase sigma factor in Bacillus subtilis. J Bacteriol (1987) 3.62
Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun (1978) 3.23
Opsonic, agglutinating, and complement-fixing antibodies in patients with subacute bacterial endocarditis. J Lab Clin Med (1968) 3.20
Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med (1971) 3.14
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA (1978) 3.13
Protection of phagocytized bacteria from the killing action of antibiotics. Nature (1966) 3.12
Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis. Proc Soc Exp Biol Med (1971) 3.11
Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1977) 3.09
Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis (2007) 3.00
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics (1995) 2.87
The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest (1978) 2.83
Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun (1986) 2.80
Effect of protein A on staphylococcal opsonization. Infect Immun (1977) 2.79
Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains. Immunology (1977) 2.73
Screening of Indian plants for biological activity: I. Indian J Exp Biol (1968) 2.63
Antiphagocytic effects of staphylococcal protein A. J Immunol (1969) 2.59
The cellular immune defect in chronic mucocutaneous candidiasis. Lancet (1969) 2.53
Mutations that affect utilization of a promoter in stationary-phase Bacillus subtilis. J Bacteriol (1985) 2.50
Symptoms of bronchial hyperreactivity and asthma in relation to environmental factors. Arch Dis Child (1988) 2.47
Cyclic GMP and cell movement. Nature (1973) 2.46
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J (2004) 2.36
Influence of the alternate complement pathway in opsonization of several bacterial species. Infect Immun (1974) 2.34
Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: bactericidal capacity for streptococci. Pediatrics (1968) 2.31
Quantitation of staphylococcal protein A: Determination of equilibrium constant and number of protein A residues on bacteria. J Immunol (1970) 2.19
Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect. Lancet (1967) 2.19
Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun (1979) 2.17
Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position paper. European Society of Pediatric Allergy and Clinical Immunology. Pediatr Allergy Immunol (1993) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Opsonic activity of agammaglobulinemic human sera. J Immunol (1971) 2.13
Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun (1979) 2.08
Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology (1974) 2.08
Effect of tetracycline on the phagocytic function of human leukocytes. J Infect Dis (1974) 2.06
Cytochalasin B. IV. Inhibition and stimulation of chemotaxis of rabbit and human polymorphonuclear leukocytes. J Immunol (1972) 2.04
Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun (1978) 2.03
Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01
Rheumatoid factors in subacute bacterial endocarditis--bacterium, duration of disease or genetic predisposition? Ann Intern Med (1968) 2.00
DNA fingerprinting of Streptococcus zooepidemicus (Lancefield group C) as an aid to epidemiological study. J Infect Dis (1987) 1.99
Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet (1974) 1.98
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
Human serum interactions with Candida albicans. J Immunol (1968) 1.93
Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun (1977) 1.92
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 1.86
The devastating potential of blunt vertebral arterial injuries. Ann Surg (2000) 1.84
Interaction of E. coli strains with human serum: lack of relationship to K1 antigen. J Pediatr (1976) 1.83
Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest (1981) 1.82
Phagocytosis in subacute bacterial endocarditis. Localization of the primary opsonic site to Fc fragment. J Exp Med (1968) 1.80
Endotoxin levels in Estonian and Swedish house dust and atopy in infancy. Clin Exp Allergy (2003) 1.79
Modulation of human neutrophil chemotactic responses by cyclic 3',5'-guanosine monophosphate and cyclic 3',5'-adenosine monophosphate. Metabolism (1975) 1.78
Effects of staphylococcal protein A on heat labile opsonins. J Immunol (1974) 1.73
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. Clin Exp Allergy (2011) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes. Infect Immun (1976) 1.63
California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. Pediatrics (1973) 1.62
Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy (2009) 1.61
Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol (1997) 1.60
Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function. Semin Hematol (1968) 1.58
Cord blood levels of immunoglobulin G subclass antibodies to food and inhalant allergens in relation to maternal atopy and the development of atopic disease during the first 8 years of life. Clin Exp Allergy (2000) 1.58
Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy (2009) 1.58
Comparison of asthma prevalence in the ISAAC and the ECRHS. ISAAC Steering Committee and the European Community Respiratory Health Survey. International Study of Asthma and Allergies in Childhood. Eur Respir J (2000) 1.57
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun (1978) 1.56
Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization. Infect Immun (1983) 1.54
Serum opsonin, bacteria, and polymorphonuclear leukocyte interactions in subacute bacterial endocarditis. Anti-gamma-globulin factors and their interaction with specific opsonins. J Clin Invest (1968) 1.53
Birth weight from pregnancies dated by ultrasonography in a multicultural British population. BMJ (1993) 1.51
Occurrence of protein a in staphylococcal strains: quantitative aspects and correlation to antigenic and bacteriophage types. Infect Immun (1971) 1.51
Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy (1998) 1.50
Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria. Infect Immun (1978) 1.50
Thymus size and head circumference at birth and the development of allergic diseases. Clin Exp Allergy (2001) 1.48
Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcus aureus infections. N Engl J Med (1979) 1.47
Studies on interaction of bacteria, serum factors and polymorphonuclear leukocytes in mothers and newborns. Pediatrics (1969) 1.46
Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J (2001) 1.46
Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin. Infect Immun (1980) 1.44
Immune responses to birch in young children during their first 7 years of life. Clin Exp Allergy (2002) 1.43
Local immunotherapy is not documented for clinical use. Allergy (1994) 1.43
Fatty acid composition in colostrum and mature milk from non-atopic and atopic mothers during the first 6 months of lactation. Acta Paediatr (1998) 1.42
Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 1.41
Human polymorphonuclear leucocyte receptors for staphylococcal opsonins. Immunology (1977) 1.40
Defective polymorphonuclear-leukocyte function and chronic granulomatous disease in two female children. N Engl J Med (1968) 1.40
A penicillin-resistant pneumococcus. J Pediatr (1978) 1.40
Chronic granulomatous disease in females. N Engl J Med (1970) 1.38
Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. J Infect Dis (1981) 1.38
Comparison of phagocytic and chemiluminescence response of human polymorphonuclear neutrophils. J Lab Clin Med (1977) 1.37
Klebsiella type 33 septicemia in an infant intensive care unit. J Pediatr (1972) 1.37
Complement-mediated phagocytosis of Pseudomonas aeruginosa. J Lab Clin Med (1978) 1.37
Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr (1969) 1.37
Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med (1975) 1.36
Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass. J Immunol Methods (1983) 1.36
X-linked inheritance in females with chronic granulomatous disease. J Clin Invest (1980) 1.35
Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy (2000) 1.35
Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla. J Infect Dis (1976) 1.31